NICE issues preliminary decision on FORXIGA medicine
As part of the appraisal, NICE has issued a ‘Minded Not to Recommend’ and requested for the further information and analysis on the submitted cost-effectiveness model. Used as
The US Food and Drug Administration (FDA) has declined to approve Unicycive Therapeutics’ resubmitted new drug application (NDA) for oxylanthanum carbonate (OLC) to treat hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis.
Cetac is involved in providing sample handling and introduction products including autosamplers, autodilutors, liquid handling platforms and sample preparation stations to pharmaceutical, life sciences, clinical/forensic and separation sciences,
Auvi-Q (epinephrine injection), which the company claims is the first-and-only epinephrine auto-injector with audio and visual cues, features an automatic retractable needle mechanism to help prevent accidental needle